HNN3.0
Register
Register
Register

Project cooperationUpdated on 22 January 2026

iPSC-derived neuronal models in 2D and 3D

PI at Masaryk University

Brno, Czech Republic

About

We offer a comprehensive portfolio of human iPSC-derived neuronal models in both 2D and 3D formats, including induced neurons, mixed neuronal–glial cultures, cerebral organoids, and advanced co-culture systems (e.g. neuron–glia and tumor–brain organoid models).

Our models are primarily applied to the study of neurodegenerative and neuropsychiatric disorders, with a strong focus on Alzheimer’s disease, glioblastoma, and schizophrenia, as well as gene- and pathway-specific mechanisms underlying neuronal dysfunction, neuroinflammation, and treatment resistance.

Available assays and readouts include:

  • standard molecular biology assays (qPCR, WB, ELISA, FACS)

  • immunocytochemistry and histology,

  • fluorescent microscopy, high-content and live-cell imaging,

  • electron microscopy (SEM, TEM)

  • single-cell and bulk RNA sequencing,

  • proteomics and pathway analysis,

  • electrophysiology (MEA),

  • calcium imaging,

  • functional assays of trafficking, synaptic activity, and cell viability,

  • drug and inhibitor testing in 2D cultures, organoids, and tumoroids.

These platforms enable mechanistic studies, target validation, and preclinical drug testing in human-relevant neuronal systems.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Type

  • Partner seeks Consortium/Coordinator

Organisation

Masaryk University

University

Brno, Czech Republic

Similar opportunities

  • Project cooperation

    Organoids and bionanomaterials customization

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Fabrizio Gelain

    PI at IRCCS Casa Sollievo della Sofferenza

    San Giovanni Rotondo, Italy

  • Project cooperation

    Regenerative medicine ATMPs for T1D

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)

    András Dinnyés

    Co-founder and General Director at BioTalentum

    Godollo, Hungary

  • Project cooperation

    Organ on chips, organoids and other NAMs for biomedical research

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Joude Cachoux

    Business Development Manager, PharmD, MPH at LEITAT

    Barcelona, Spain